RSS Feed for This PostCurrent Article

Dealing with downstream pain…

Firms on both buy and sell sides want to do more OTC derivatives and structured products trading, and indeed in light of the credit crunch have had no choice but to do so. But how can they ensure that back office bottlenecks don’t put a brake on trading strategies?

By Thea George

The credit derivatives confirmations backlog that kicked off the past years’ focus on improving straight-through processing (STP) for OTC derivatives is somewhat old hat these days – or, more accurately, it was, until the “credit crunch” provoked a surge in volumes and back offices started to creak under the strain again.

Get A-Team IQ delivered to your desk free if you are a newsletter subscriber. Or click here to purchase a subscription.

Existing Users Login

Email: 
Password: 

Free User Registration

To create a free user account which grants you access to an entire library of free issues, articles, and research reports (click here for the full list) fill out and submit the form below.

* Required
Email (as login):* 
Confirm Email:* 
First Name:* 
Last Name:* 
Company: 
Department: 
Job Title: 
Day Phone:* 
Mobile: 
Fax: 
Address:* 
Address 2: 
City:* 
State/Province/Suburb:* 
Postal Code/Zip:* 
Country:*